Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | AR | P10275 | 4/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6558245 | 0.91 | MAPT (0.40) | MAPTRAB9ASMN1; SMN2ARLMNA | |
| SCHEMBL6556267 | 0.90 | FOS (0.43) | MAPTRAB9ASMN1; SMN2GAALMNA | |
| SCHEMBL6558338 | 0.87 | KDM4E (0.50) | MAPTRAB9AGAALMNAMEN1 | |
| SCHEMBL6556171 | 0.85 | GAA (0.45) | MAPTRAB9ASMN1; SMN2GAALMNA | |
| SCHEMBL6557695 | 0.85 | NPC1 (0.48) | RAB9ASMN1; SMN2GAALMNAPOLB | |
| SCHEMBL6558284 | 0.85 | KDM4E (0.53) | MAPTRAB9ASMN1; SMN2GAALMNA | |
| SCHEMBL6558325 | 0.85 | KDM4E (0.49) | MAPTRAB9ASMN1; SMN2GAALMNA | |
| SCHEMBL6556112 | 0.84 | CSNK1D (0.45) | MAPTGAALMNAMEN1KMT2A | |
| SCHEMBL6556372 | 0.81 | AKR1B1 (0.36) | MAPTRAB9ASMN1; SMN2LMNAMEN1 | |
| SCHEMBL6558388 | 0.81 | KDM4E (0.49) | MAPTRAB9ASMN1; SMN2GAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0826671-B1 | HETEROCYCLIC AMIDE COMPOUNDS AND MEDICINAL USE OF THE SAME | MITSUBISHI PHARMA CORP (JP) | 2004-12-29 | — | — | EP | disclosed |
| US-5948785-A | USEFUL AS CHYMASE INHIBITORS AND CAN BE EFFECTIVE FOR THE PROPHYLAXIS AND TREATMENT OF VARIOUS DISEASES CAUSED BY CHYMASE, SUCH AS THOSE CAUSED BY ANGIOTENSIN II. | THE GREEN CROSS CORPORATION (JP) | 1999-09-07 | — | — | US | disclosed |
| EP-0826671-A1 | HETEROCYCLIC AMIDE COMPOUNDS AND MEDICINAL USE OF THE SAME | THE GREEN CROSS CORPORATION (JP) | 1998-03-04 | — | — | EP | disclosed |